Sorry, you need to enable JavaScript to visit this website.

Skip to main content


Contact Janssen Neuroscience

Contact Neuroscience at Janssen
Licensing and Acquisition Activities

Representatives of established pharmaceutical companies, mid-sized and large biotechnology companies, individuals with opportunities that have achieved clinical proof of concept, and those with interests in licensing and acquisition activities, please contact:

Lucinda Warren
Vice President, Business Development, Neuroscience
Phone: +1-732-524-2395
Email: [email protected]

Early Stage Opportunities

The Johnson & Johnson Innovation Center team is responsible for partnership opportunities prior to clinical proof of concept. For more information contact:

  • California Innovation Center covers Western US and Canada, and Australia: Guy Seabrook, Ph.D., Vice President & Global Lead, Neuroscience External Innovation.
  • Boston Innovation Center covers the Eastern US and Canada, and Midwestern US: Eric Schaeffer, Ph.D., Senior Director, Neuroscience External Innovation
  • London Innovation Center covers:
    • UK/EMEA: Declan Jones, Ph.D., Vice President, Neuroscience External Innovation
    • Israel: John Isaac, Ph.D., Senior Director, Neuroscience External Innovation
    • Asia-Pacific Innovation Center: Stefan Hart, Senior Director, New Ventures Singapore & India

For more information about the interests of the Neuroscience team or for other therapeutic indications, please see our website:

We appreciate your interest in partnering with Janssen. For complete information, please review our “Partnering in Neuroscience” brochure.


If you are a member of the media, and need to reach our Research & Development Media Relations team, please contact Janssen Research & Development.

To reach a member of our Therapeutic Area or Regional Media Relations team, please visit our Media Relations page.




Nerve fibers
Nerve fibers